Overview / Abstract: |
At WORLDSymposium 2020, new information and data were presented on Mucopolysaccharidoses (MPSs), a group of genetic lysosomal disorders. This CME activity highlights the latest information about MPSs from WORLDSymposium and provides expert analysis of its clinical relevance for busy members of the care team in order to help them care for patients with these rare diseases. |
Expiration |
May 01, 2021 |
Discipline(s) |
Nurse Practitioner , Nursing CNE, Physical Therapy CE, Physician CME, Physician Assistant CME |
Format |
Webinar / Webcast / Video |
Credits / Hours |
.25 |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Barbara K. Burton, MD |
Activity Specialities / Related Topics |
Primary Care, Pediatrics, Osteopathy / Osteopathic Medicine , Neurology, Internal Medicine, Hematology, Genetics, Gastroenterology / GI, Education / Teaching |
Sponsors / Supporters / Grant Providers |
Ultragenyx Pharmaceutical Inc. |
Keywords / Search Terms |
CheckRare Mucopolysaccharidoses, MPS, inherited metabolic disease, rare disease, MPS IIIA, heparan N-sulfatase MPS IIIB, alpha-N-acetylglucosaminidase MPS IIIC, acetyl-CoA:alpha-glucosaminide acetyltransferase, MPS IIID, Hurler Syndrome, Hurler-Scheie Syndrome, Scheie Syndrome, Hunter Syndrome, Sanfilippo Syndrome, Morquio Syndrome, Maroteaux-Lamy Syndrome, Sly Syndrome, lysosomal storage disorder, Barbara Burton MD, WORLDSYM |